查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2058473

口臭治療市場：按類型、治療方法和地區分類

Halitosis Treatment Market, By Type (Pathological and Non-pathological), By Treatment (Antacids, Antiseptics, Antiplaque, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
出版日期: | 出版商: Coherent Market Insights | 英文 255 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

據估計，2026年口臭治療市值為177億美元，預計2033年將達到356億美元。預計從2026年到2033年，該市場將以10.5%的複合年成長率成長。

分析範圍 分析詳情
基準年 2025 市場規模（2026 年） 177億美元
效能數據 2020-2024 預測期 2026-2033
預測期（2026-2033 年）複合年成長率 10.50% 預計金額（2033 年） 356億美元

口臭可能由口腔內外因素引起。這是由於病理性或非病理性原因產生的揮發性分子所致。這些揮發性化合物包括芳香族化合物、含硫化合物、短鏈脂肪酸、含氮化合物、胺類、脂肪族化合物、醇類或苯基化合物以及酮類。

口臭的原因多種多樣，包括喉癌、鼻咽氣喘以及下呼吸道感染疾病，例如氣喘、支氣管擴張、慢性支氣管炎、囊腫纖維化、間質性肺病和肺炎。根據2012年發表在《國際口腔科學雜誌》上的一項研究，約10%的口臭病例源自於耳、鼻、咽喉部位，其中3%是由扁桃體引起的。

市場動態

菸草和酒精消費量的增加、扁桃體炎、鼻咽喉及鼻竇發炎等疾病、代謝紊亂是推動口臭治療市場成長的主要因素。根據美國國家生物技術資訊中心 (NCBI) 2013 年的研究，口臭非常普遍，影響全球約 50% 的人口。

口臭的成因多種多樣，但約90%的病例源自於口腔，包括口腔衛生不良、舌苔、牙周病、假牙不潔、食物殘渣滯留、口腔癌、修復體不合適、咽喉感染疾病。治療口臭至關重要，因為它可能引發壓力等嚴重問題。 2018年，口臭研究所的研究發現，口臭患者承受壓力的可能性高出60%，57%的口臭患者表示因此出現憂鬱症症狀。然而，發展中國家對口臭的認知度較低，可能會限制口臭治療市場的發展。

本報告的主要特點

  • 本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
  • 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
  • 本頁面根據各種參數（公司概況、財務表現、產品系列、企業發展區域、分銷策略、主要趨勢和策略等）對全球口臭治療市場的主要公司進行了介紹。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
  • 《全球口臭治療市場》報告面向該行業的眾多相關人員，包括投資者、產品製造商、經銷商、口臭治療供應商、研究和諮詢公司、新進業者和金融分析師。
  • 相關人員可以透過分析全球口臭治療市場中使用的各種策略矩陣來促進決策。

目錄

第1章：分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 流行病學分析
  • 波特五力分析

第4章：全球口臭治療市場：按類型分類（2021-2033 年）

  • 病理
  • 非病理性的

第5章：全球口臭治療市場：依治療方法分類（2021-2033 年）

  • 制酸劑
  • 消毒劑
  • 斑塊（牙菌斑形成劑）
  • 其他

第6章：全球口臭治療市場：按地區分類（2021-2033 年）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 非洲
    • 北非
    • 中非
    • 南非
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家

第7章 競爭情勢

  • 熱圖分析
  • 公司簡介
    • Abbott Laboratories
    • AstraZeneca Plc.
    • Colgate-Palmolive Company
    • Dr. Harold Katz
    • Listerine
    • Rowpar Pharmaceuticals

第8章

  • 參考
  • 分析方法
簡介目錄
Product Code: CMI2219

Halitosis Treatment Market is estimated to be valued at USD 17.7 Bn in 2026 and is expected to reach USD 35.6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 17.7 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 10.50% 2033 Value Projection: USD 35.6 Bn

Halitosis originates from an oral or a non-oral source. It is caused by volatile molecules, which are developed due to pathological or non-pathological reasons. These volatile compounds are aromatic compounds, sulphur compounds, short-chain fatty acids, nitrogen-containing compounds, amines, aliphatic compounds, alcohols or phenyl compounds, and ketones.

Various causes of halitosis include cancer of the larynx, nasopharyngeal abscess, and lower respiratory tract infections such as asthma, bronchiectasis, chronic bronchitis, bronchiectasis, lung abscess, cystic fibrosis, interstitial lung diseases, and pneumonia. According to the International Journal of Oral Science 2012 study, around 10% of the oral malodor cases originate from the ears, nose and throat region, and 3% of it occur due to tonsils.

Market Dynamics

Increasing consumption of tobacco and alcohol, medical condition such as tonsils and inflammation of nose, throat or sinuses and metabolic diseases are the major factors driving the halitosis treatment market growth. According to the National Center for Biotechnology Information (NCBI) 2013 study, halitosis is very common and affects around 50% of the general population around the world.

Although halitosis has multifactorial origins, around 90% cases occur due to oral cavity such as poor oral hygiene, tongue coat, periodontal disease, unclean dentures, food impaction, oral carcinomas, faulty restorations, and throat infections. Treatment of halitosis is very important, as it can cause serious conditions such as stress. According to the Bad Breath Institute 2018 study, people with halitosis are 60% more likely to suffer from stress, while 57% of bad breath sufferers report feelings of depression due to their condition. However, lack of awareness among the under developed regions can confine the halitosis treatment market growth.

Key features of the study

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global halitosis treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Abbott Laboratories, AstraZeneca Plc, Colgate-Palmolive Company, Dr. Harold Katz, Listerine, and Rowpar Pharmaceuticals
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global halitosis treatment market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for halitosis treatment market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

  • By Type Insights (Revenue, USD Bn, 2021 - 2033)
    • Pathological
    • Non-pathological
  • By Treatment Insights (Revenue, USD Bn, 2021 - 2033)
    • Antacids
    • Antiseptics
    • Antiplaque
    • Others
  • By Region Insights (Revenue, USD Bn, 2021 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players
    • Abbott Laboratories
    • AstraZeneca Plc.
    • Colgate-Palmolive Company
    • Harold Katz
    • Listerine
    • Rowpar Pharmaceuticals

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Treatment
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Epidemiology Analysis
  • PORTER'S Five Forces

4. Global Halitosis Treatment Market, By Type, 2021 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Pathological
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
  • Non-pathological
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

5. Global Halitosis Treatment Market, By Treatment, 2021 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Antacids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
  • Antiseptics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
  • Antiplaque
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

6. Global Halitosis Treatment Market, By Region, 2021 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, By Region, 2022 - 2033
    • Regional Trends
  • North America
    • Market Size and Forecast, By Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, By Treatment, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, By Country, 2021 - 2033, (US$ Billion)
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast, By Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, By Treatment, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, By Country, 2021 - 2033, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, By Treatment, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, By Country, 2021 - 2033, (US$ Billion)
      • China
      • Japan
      • India
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, By Treatment, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, By Country, 2021 - 2033, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, By Treatment, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, By Country, 2021 - 2033, (US$ Billion)
      • North Africa
      • Central Africa
      • South Africa
  • Middle East
    • Market Size and Forecast, By Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, By Treatment, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, By Country, 2021 - 2033, (US$ Billion)
      • GCC Countries
      • Israel
      • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Abbott Laboratories
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • AstraZeneca Plc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Colgate-Palmolive Company
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Dr. Harold Katz
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Listerine
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Rowpar Pharmaceuticals
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
      • Analyst Views

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact